High concordance of programmed death-ligand 1 expression with immunohistochemistry detection between antibody clones 22C3 and E1L3N in non-small cell lung cancer biopsy samples

BACKGROUND: The detection of programmed death-ligand 1 (PD-L1) expression can enrich for patients who respond to anti-programmed cell death 1 (PD-1)/PD-L1 therapies. Though, for most laboratories, the cost of PD-L1 22C3 pharmDx is prohibitive for widespread use, whereas the laboratory-developed test...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Cao, Ziyang, Gao, Caixia, Huang, Yan, Wu, Chunyan, Zhang, Liping, Hou, Likun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798544/
https://www.ncbi.nlm.nih.gov/pubmed/35117196
http://dx.doi.org/10.21037/tcr-20-101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798544/
https://www.ncbi.nlm.nih.gov/pubmed/35117196
http://dx.doi.org/10.21037/tcr-20-101

Ejemplares similares